<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/FF95163E-02EC-4889-A6AE-88F3503BA786"><gtr:id>FF95163E-02EC-4889-A6AE-88F3503BA786</gtr:id><gtr:name>Government of France</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AAA90310-B621-460B-B530-35ADEE45DB78"><gtr:id>AAA90310-B621-460B-B530-35ADEE45DB78</gtr:id><gtr:name>C.H. Boehringer Sohn AG &amp; Ko. KG</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C7F1BFE1-7849-406B-85EE-AF86E3409D90"><gtr:id>C7F1BFE1-7849-406B-85EE-AF86E3409D90</gtr:id><gtr:name>Netherlands Organisation for Health Research and Development (ZonMw)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/665A34CB-4ED4-40A0-8070-BD590E7EB42B"><gtr:id>665A34CB-4ED4-40A0-8070-BD590E7EB42B</gtr:id><gtr:name>UK Biobank</gtr:name><gtr:address><gtr:line1>1-2 Spectrum Way</gtr:line1><gtr:line2>Adswood</gtr:line2><gtr:postCode>SK3 0SA</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A8F2AA65-FB13-45D8-96BA-E478CE387554"><gtr:id>A8F2AA65-FB13-45D8-96BA-E478CE387554</gtr:id><gtr:name>Karolinska University Hospital</gtr:name><gtr:address><gtr:line1>Karolinska University Hospital</gtr:line1><gtr:line2>Huddinge</gtr:line2><gtr:postCode>SE 141 86</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DFBABDBD-1EE6-4125-96A9-35DDA31FBAF8"><gtr:id>DFBABDBD-1EE6-4125-96A9-35DDA31FBAF8</gtr:id><gtr:name>Federal Ministry of Science, Research and Economy (BMWFW)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/EC177B1F-35EE-4B74-981D-E8382EE3D18C"><gtr:id>EC177B1F-35EE-4B74-981D-E8382EE3D18C</gtr:id><gtr:name>London School of Economics &amp; Pol Sci</gtr:name><gtr:address><gtr:line1>Houghton Street</gtr:line1><gtr:line2>Aldwych</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>WC2A 2AE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/FAE32A25-51D3-49EF-998F-281B3A47C212"><gtr:id>FAE32A25-51D3-49EF-998F-281B3A47C212</gtr:id><gtr:name>Helmholtz Association of German Research Centres</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/07DB7304-CC6B-46CF-B9E7-70380E52285B"><gtr:id>07DB7304-CC6B-46CF-B9E7-70380E52285B</gtr:id><gtr:name>Sanofi</gtr:name><gtr:address><gtr:line1>54 rue de la Boetie</gtr:line1><gtr:postCode>F-75008</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/257C5108-1625-44DA-8C36-1FBC1CEF564E"><gtr:id>257C5108-1625-44DA-8C36-1FBC1CEF564E</gtr:id><gtr:name>King's College Hospital Charitable Trust</gtr:name><gtr:address><gtr:line1>King's College Hospital</gtr:line1><gtr:line2>Denamark Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SE8 9RS</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F0678985-3705-4E70-9B10-6E3ECB46F12F"><gtr:id>F0678985-3705-4E70-9B10-6E3ECB46F12F</gtr:id><gtr:name>European Molecular Biology Laboratory (EMBL)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/01128021-52EB-4EFB-B0E5-437538E9F785"><gtr:id>01128021-52EB-4EFB-B0E5-437538E9F785</gtr:id><gtr:name>Almirall</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A3F0E7CF-8EB7-43CB-BF51-DF1B3AE5C6DD"><gtr:id>A3F0E7CF-8EB7-43CB-BF51-DF1B3AE5C6DD</gtr:id><gtr:name>Lundbeck Foundation</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4320E3F8-C34A-4CB6-9C13-726ABEFC298F"><gtr:id>4320E3F8-C34A-4CB6-9C13-726ABEFC298F</gtr:id><gtr:name>National Institute for Cancer Research, Genoa (IST) (Istituto Nazionale per la Ricerca sul Cancro di Genova)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/931F0B0D-E479-4E31-AF94-5CCAFB6A4445"><gtr:id>931F0B0D-E479-4E31-AF94-5CCAFB6A4445</gtr:id><gtr:name>deCODE Genetics</gtr:name><gtr:address><gtr:line1>Sturlugata 8</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D5ABC79A-9634-458E-BD8B-089286716664"><gtr:id>D5ABC79A-9634-458E-BD8B-089286716664</gtr:id><gtr:name>Academy of Athens</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/681C1535-3857-4B97-ADE1-82DBD84698A4"><gtr:id>681C1535-3857-4B97-ADE1-82DBD84698A4</gtr:id><gtr:name>Italian National Health Service</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/0FED1C47-231B-46E3-9C8D-2CE5528F10B1"><gtr:id>0FED1C47-231B-46E3-9C8D-2CE5528F10B1</gtr:id><gtr:name>The Karolinska Institute, Stockholm</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/56443A66-B72D-4164-A2AE-F16898367510"><gtr:id>56443A66-B72D-4164-A2AE-F16898367510</gtr:id><gtr:name>Uppsala University</gtr:name><gtr:address><gtr:line1>PO Box 256</gtr:line1><gtr:postCode>SE-751 05</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/BDF36443-7BBF-442D-B7DF-90862772B70C"><gtr:id>BDF36443-7BBF-442D-B7DF-90862772B70C</gtr:id><gtr:name>Government of the Netherlands</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/92B81E1C-B58D-4789-A544-BD07D637286F"><gtr:id>92B81E1C-B58D-4789-A544-BD07D637286F</gtr:id><gtr:name>University of Klagenfurt</gtr:name><gtr:address><gtr:line1>Schottenfeldgasse 29</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DA0437CC-F637-41CB-8544-DFA50F04360C"><gtr:id>DA0437CC-F637-41CB-8544-DFA50F04360C</gtr:id><gtr:name>National Research Council CNR - Italy</gtr:name><gtr:address><gtr:line1>National Research Council CNR</gtr:line1><gtr:line2>P le Aldo Moro 7</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1A0DAB7-FD0B-415C-A58B-F4CFC655E3FC"><gtr:id>D1A0DAB7-FD0B-415C-A58B-F4CFC655E3FC</gtr:id><gtr:name>Academic Medical Center (AMC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1367D45-734D-4891-9671-3C7C7C31D0A0"><gtr:id>D1367D45-734D-4891-9671-3C7C7C31D0A0</gtr:id><gtr:name>UCB Pharma</gtr:name><gtr:address><gtr:line1>Researchdreef 60</gtr:line1><gtr:line2>Allee de la Recherche 60</gtr:line2><gtr:postCode>B-1070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/0AD63065-6AF5-4C7A-9EA2-41638DB07F74"><gtr:id>0AD63065-6AF5-4C7A-9EA2-41638DB07F74</gtr:id><gtr:name>Hellenic Republic Ministry of Development</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/6965F193-D7C9-499B-8CE2-0C573BBAA4DD"><gtr:id>6965F193-D7C9-499B-8CE2-0C573BBAA4DD</gtr:id><gtr:name>The Icelandic Centre for Research (RANN?S)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F090453F-0566-49B4-B11F-BD6B73A64E03"><gtr:id>F090453F-0566-49B4-B11F-BD6B73A64E03</gtr:id><gtr:name>University of Vienna</gtr:name><gtr:address><gtr:line1>Dr-Karl-L?ger-Ring 1</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/48248E4C-A084-4BFD-864A-CDAA5513BA7B"><gtr:id>48248E4C-A084-4BFD-864A-CDAA5513BA7B</gtr:id><gtr:name>Molecular Medicine Ireland</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A0BACE25-B55C-4EDF-B5EF-2E48E933C631"><gtr:id>A0BACE25-B55C-4EDF-B5EF-2E48E933C631</gtr:id><gtr:name>University of Tartu</gtr:name><gtr:address><gtr:line1>Ulikooli 18</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Estonia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C6BEF6ED-BF47-40E2-917A-4FF3149DE30B"><gtr:id>C6BEF6ED-BF47-40E2-917A-4FF3149DE30B</gtr:id><gtr:name>German Federal Ministry of Education and Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1A60B063-E58F-4072-A2EA-8474BE302464"><gtr:id>1A60B063-E58F-4072-A2EA-8474BE302464</gtr:id><gtr:name>International Agency for Research on Cancer (IARC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/BCAE40A9-5A38-4B94-A742-AEDAD7D4681F"><gtr:id>BCAE40A9-5A38-4B94-A742-AEDAD7D4681F</gtr:id><gtr:name>Leiden University Medical Centre</gtr:name><gtr:address><gtr:line1>PO Box 9600</gtr:line1><gtr:line4>Leiden</gtr:line4><gtr:line5>NL-2300 RC</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/55E3189A-E372-4C13-AD98-87C6C754D4B3"><gtr:id>55E3189A-E372-4C13-AD98-87C6C754D4B3</gtr:id><gtr:name>Babraham Bioscience Technologies</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/CA10F5D0-8E26-4790-BF21-025009DDA322"><gtr:id>CA10F5D0-8E26-4790-BF21-025009DDA322</gtr:id><gtr:name>Medical University of Graz</gtr:name><gtr:address><gtr:line1>Harrachgasse 21</gtr:line1><gtr:line4>Graz</gtr:line4><gtr:line5>A-8010</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Austria</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7834FF12-A0B3-48E0-BA8C-39F517E844C4"><gtr:id>7834FF12-A0B3-48E0-BA8C-39F517E844C4</gtr:id><gtr:name>Government of Estonia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E594C221-4738-4152-9CFD-57F6EB31C620"><gtr:id>E594C221-4738-4152-9CFD-57F6EB31C620</gtr:id><gtr:name>Fraunhofer Society</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DA82066A-2B1B-412F-8D72-43273A319CA6"><gtr:id>DA82066A-2B1B-412F-8D72-43273A319CA6</gtr:id><gtr:name>Roche</gtr:name><gtr:address><gtr:line1>PRG Building 93 room 6 10</gtr:line1><gtr:line2>F Hoffman La Roche</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A620A19B-1A40-418A-B3FC-086E667D691D"><gtr:id>A620A19B-1A40-418A-B3FC-086E667D691D</gtr:id><gtr:name>Norwegian University of Science and Technology</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/00866200-F62B-429B-BF02-A0A841684ED5"><gtr:id>00866200-F62B-429B-BF02-A0A841684ED5</gtr:id><gtr:name>University of Salamanca</gtr:name><gtr:address><gtr:line1>Universidad de Salamanca</gtr:line1><gtr:line2>Patio de Escuelas 1</gtr:line2><gtr:line4>Salamanca</gtr:line4><gtr:line5>37071</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D3CC600D-1AD4-4272-99C1-158BDF55308C"><gtr:id>D3CC600D-1AD4-4272-99C1-158BDF55308C</gtr:id><gtr:name>Alliance Against Cancer</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/326EF7F4-5944-472D-BC94-2CA4484AEE74"><gtr:id>326EF7F4-5944-472D-BC94-2CA4484AEE74</gtr:id><gtr:name>University of Groningen</gtr:name><gtr:address><gtr:line1>Postbus 72</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3F817F1C-4D4C-4325-A83C-601A871E5487"><gtr:id>3F817F1C-4D4C-4325-A83C-601A871E5487</gtr:id><gtr:name>ORION Pharma</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E3D2D81D-2671-410B-9D1C-BBBBDA8CF466"><gtr:id>E3D2D81D-2671-410B-9D1C-BBBBDA8CF466</gtr:id><gtr:name>Johnson &amp; Johnson Ltd</gtr:name><gtr:address><gtr:line1>Foundation Park</gtr:line1><gtr:line2>Roxborough Way</gtr:line2><gtr:line4>Maidenhead</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>SLG 3UG</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A41945D6-8D29-453B-9D65-95BA3A272A1D"><gtr:id>A41945D6-8D29-453B-9D65-95BA3A272A1D</gtr:id><gtr:name>International Rare Diseases Research Consortium (IRDiRC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DD698BE9-1ED7-42BF-AC5D-427A5CA5851D"><gtr:id>DD698BE9-1ED7-42BF-AC5D-427A5CA5851D</gtr:id><gtr:name>Bayer</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/ADD77807-7B00-4A41-A7A4-09A5D0BB801C"><gtr:id>ADD77807-7B00-4A41-A7A4-09A5D0BB801C</gtr:id><gtr:name>Esteve</gtr:name><gtr:address><gtr:line1>Avda. Mare de Deu de Montserrat, 221</gtr:line1><gtr:postCode>E-08041</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/82321AD2-CD2E-456C-9395-59CF155A3EC8"><gtr:id>82321AD2-CD2E-456C-9395-59CF155A3EC8</gtr:id><gtr:name>Sanofi</gtr:name><gtr:address><gtr:line1>174 avenue de France</gtr:line1><gtr:line4>Paris cedex 13</gtr:line4><gtr:postCode>75635</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/712757B9-CD96-4383-A0F9-F0D7F1B4951C"><gtr:id>712757B9-CD96-4383-A0F9-F0D7F1B4951C</gtr:id><gtr:name>Vitro (Biobanking services)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/98C379BE-5412-4C64-9838-F46315C76505"><gtr:id>98C379BE-5412-4C64-9838-F46315C76505</gtr:id><gtr:name>Health Research Board (HRB)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/8F8BCFC1-FF94-4796-B5E0-5A64B0C3AB6C"><gtr:id>8F8BCFC1-FF94-4796-B5E0-5A64B0C3AB6C</gtr:id><gtr:name>Autonomous University of Madrid</gtr:name><gtr:address><gtr:line1>Ciudad Universitaria de Cantoblanco</gtr:line1><gtr:line2>C/Francisco Tomas y Valiente, 1</gtr:line2><gtr:line4>Madrid</gtr:line4><gtr:line5>E-28049</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/314A3F92-9F78-4782-891F-990F9E739DC4"><gtr:id>314A3F92-9F78-4782-891F-990F9E739DC4</gtr:id><gtr:name>Medical University of Vienna</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/6A5D0F02-E386-44C0-BBAE-17AAC62AF2BA"><gtr:id>6A5D0F02-E386-44C0-BBAE-17AAC62AF2BA</gtr:id><gtr:name>Netherlands Federation of University Medical Centres (NFU)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/6C747631-6855-48CC-BF64-0316AABB5DF8"><gtr:id>6C747631-6855-48CC-BF64-0316AABB5DF8</gtr:id><gtr:name>University of Malta</gtr:name><gtr:address><gtr:line1>Administration Bldg</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/61D20CC7-787C-455B-936A-3E16D0122205"><gtr:id>61D20CC7-787C-455B-936A-3E16D0122205</gtr:id><gtr:name>Semmelweis University</gtr:name><gtr:address><gtr:line1>Semmelweis University</gtr:line1><gtr:line2>Alkotas u. 44</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/620DB27D-4014-4278-AAD1-11105CC6BDEA"><gtr:id>620DB27D-4014-4278-AAD1-11105CC6BDEA</gtr:id><gtr:name>Novo Nordisk</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5A8C32C1-29FC-4B3A-8C07-C792DC7AF31B"><gtr:id>5A8C32C1-29FC-4B3A-8C07-C792DC7AF31B</gtr:id><gtr:name>Legal Pathways Institute for Health and Bio-Law</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5F32098B-3CD7-41E1-BD83-220F3383C071"><gtr:id>5F32098B-3CD7-41E1-BD83-220F3383C071</gtr:id><gtr:name>Spanish Ministry of Science and Innovation</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Medical and Human Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/FF95163E-02EC-4889-A6AE-88F3503BA786"><gtr:id>FF95163E-02EC-4889-A6AE-88F3503BA786</gtr:id><gtr:name>Government of France</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AAA90310-B621-460B-B530-35ADEE45DB78"><gtr:id>AAA90310-B621-460B-B530-35ADEE45DB78</gtr:id><gtr:name>C.H. Boehringer Sohn AG &amp; Ko. KG</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C7F1BFE1-7849-406B-85EE-AF86E3409D90"><gtr:id>C7F1BFE1-7849-406B-85EE-AF86E3409D90</gtr:id><gtr:name>Netherlands Organisation for Health Research and Development (ZonMw)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/665A34CB-4ED4-40A0-8070-BD590E7EB42B"><gtr:id>665A34CB-4ED4-40A0-8070-BD590E7EB42B</gtr:id><gtr:name>UK Biobank</gtr:name><gtr:address><gtr:line1>1-2 Spectrum Way</gtr:line1><gtr:line2>Adswood</gtr:line2><gtr:postCode>SK3 0SA</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A8F2AA65-FB13-45D8-96BA-E478CE387554"><gtr:id>A8F2AA65-FB13-45D8-96BA-E478CE387554</gtr:id><gtr:name>Karolinska University Hospital</gtr:name><gtr:address><gtr:line1>Karolinska University Hospital</gtr:line1><gtr:line2>Huddinge</gtr:line2><gtr:postCode>SE 141 86</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DFBABDBD-1EE6-4125-96A9-35DDA31FBAF8"><gtr:id>DFBABDBD-1EE6-4125-96A9-35DDA31FBAF8</gtr:id><gtr:name>Federal Ministry of Science, Research and Economy (BMWFW)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EC177B1F-35EE-4B74-981D-E8382EE3D18C"><gtr:id>EC177B1F-35EE-4B74-981D-E8382EE3D18C</gtr:id><gtr:name>London School of Economics &amp; Pol Sci</gtr:name><gtr:address><gtr:line1>Houghton Street</gtr:line1><gtr:line2>Aldwych</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>WC2A 2AE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/FAE32A25-51D3-49EF-998F-281B3A47C212"><gtr:id>FAE32A25-51D3-49EF-998F-281B3A47C212</gtr:id><gtr:name>Helmholtz Association of German Research Centres</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/07DB7304-CC6B-46CF-B9E7-70380E52285B"><gtr:id>07DB7304-CC6B-46CF-B9E7-70380E52285B</gtr:id><gtr:name>Sanofi</gtr:name><gtr:address><gtr:line1>54 rue de la Boetie</gtr:line1><gtr:postCode>F-75008</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/257C5108-1625-44DA-8C36-1FBC1CEF564E"><gtr:id>257C5108-1625-44DA-8C36-1FBC1CEF564E</gtr:id><gtr:name>King's College Hospital Charitable Trust</gtr:name><gtr:address><gtr:line1>King's College Hospital</gtr:line1><gtr:line2>Denamark Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SE8 9RS</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F0678985-3705-4E70-9B10-6E3ECB46F12F"><gtr:id>F0678985-3705-4E70-9B10-6E3ECB46F12F</gtr:id><gtr:name>European Molecular Biology Laboratory (EMBL)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/01128021-52EB-4EFB-B0E5-437538E9F785"><gtr:id>01128021-52EB-4EFB-B0E5-437538E9F785</gtr:id><gtr:name>Almirall</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A3F0E7CF-8EB7-43CB-BF51-DF1B3AE5C6DD"><gtr:id>A3F0E7CF-8EB7-43CB-BF51-DF1B3AE5C6DD</gtr:id><gtr:name>Lundbeck Foundation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4320E3F8-C34A-4CB6-9C13-726ABEFC298F"><gtr:id>4320E3F8-C34A-4CB6-9C13-726ABEFC298F</gtr:id><gtr:name>National Institute for Cancer Research, Genoa (IST) (Istituto Nazionale per la Ricerca sul Cancro di Genova)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/931F0B0D-E479-4E31-AF94-5CCAFB6A4445"><gtr:id>931F0B0D-E479-4E31-AF94-5CCAFB6A4445</gtr:id><gtr:name>deCODE Genetics</gtr:name><gtr:address><gtr:line1>Sturlugata 8</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D5ABC79A-9634-458E-BD8B-089286716664"><gtr:id>D5ABC79A-9634-458E-BD8B-089286716664</gtr:id><gtr:name>Academy of Athens</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/681C1535-3857-4B97-ADE1-82DBD84698A4"><gtr:id>681C1535-3857-4B97-ADE1-82DBD84698A4</gtr:id><gtr:name>Italian National Health Service</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/0FED1C47-231B-46E3-9C8D-2CE5528F10B1"><gtr:id>0FED1C47-231B-46E3-9C8D-2CE5528F10B1</gtr:id><gtr:name>The Karolinska Institute, Stockholm</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/56443A66-B72D-4164-A2AE-F16898367510"><gtr:id>56443A66-B72D-4164-A2AE-F16898367510</gtr:id><gtr:name>Uppsala University</gtr:name><gtr:address><gtr:line1>PO Box 256</gtr:line1><gtr:postCode>SE-751 05</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/BDF36443-7BBF-442D-B7DF-90862772B70C"><gtr:id>BDF36443-7BBF-442D-B7DF-90862772B70C</gtr:id><gtr:name>Government of the Netherlands</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/92B81E1C-B58D-4789-A544-BD07D637286F"><gtr:id>92B81E1C-B58D-4789-A544-BD07D637286F</gtr:id><gtr:name>University of Klagenfurt</gtr:name><gtr:address><gtr:line1>Schottenfeldgasse 29</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DA0437CC-F637-41CB-8544-DFA50F04360C"><gtr:id>DA0437CC-F637-41CB-8544-DFA50F04360C</gtr:id><gtr:name>National Research Council CNR - Italy</gtr:name><gtr:address><gtr:line1>National Research Council CNR</gtr:line1><gtr:line2>P le Aldo Moro 7</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1A0DAB7-FD0B-415C-A58B-F4CFC655E3FC"><gtr:id>D1A0DAB7-FD0B-415C-A58B-F4CFC655E3FC</gtr:id><gtr:name>Academic Medical Center (AMC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1367D45-734D-4891-9671-3C7C7C31D0A0"><gtr:id>D1367D45-734D-4891-9671-3C7C7C31D0A0</gtr:id><gtr:name>UCB Pharma</gtr:name><gtr:address><gtr:line1>Researchdreef 60</gtr:line1><gtr:line2>Allee de la Recherche 60</gtr:line2><gtr:postCode>B-1070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/0AD63065-6AF5-4C7A-9EA2-41638DB07F74"><gtr:id>0AD63065-6AF5-4C7A-9EA2-41638DB07F74</gtr:id><gtr:name>Hellenic Republic Ministry of Development</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/6965F193-D7C9-499B-8CE2-0C573BBAA4DD"><gtr:id>6965F193-D7C9-499B-8CE2-0C573BBAA4DD</gtr:id><gtr:name>The Icelandic Centre for Research (RANN?S)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F090453F-0566-49B4-B11F-BD6B73A64E03"><gtr:id>F090453F-0566-49B4-B11F-BD6B73A64E03</gtr:id><gtr:name>University of Vienna</gtr:name><gtr:address><gtr:line1>Dr-Karl-L?ger-Ring 1</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/48248E4C-A084-4BFD-864A-CDAA5513BA7B"><gtr:id>48248E4C-A084-4BFD-864A-CDAA5513BA7B</gtr:id><gtr:name>Molecular Medicine Ireland</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A0BACE25-B55C-4EDF-B5EF-2E48E933C631"><gtr:id>A0BACE25-B55C-4EDF-B5EF-2E48E933C631</gtr:id><gtr:name>University of Tartu</gtr:name><gtr:address><gtr:line1>Ulikooli 18</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Estonia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C6BEF6ED-BF47-40E2-917A-4FF3149DE30B"><gtr:id>C6BEF6ED-BF47-40E2-917A-4FF3149DE30B</gtr:id><gtr:name>German Federal Ministry of Education and Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1A60B063-E58F-4072-A2EA-8474BE302464"><gtr:id>1A60B063-E58F-4072-A2EA-8474BE302464</gtr:id><gtr:name>International Agency for Research on Cancer (IARC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/BCAE40A9-5A38-4B94-A742-AEDAD7D4681F"><gtr:id>BCAE40A9-5A38-4B94-A742-AEDAD7D4681F</gtr:id><gtr:name>Leiden University Medical Centre</gtr:name><gtr:address><gtr:line1>PO Box 9600</gtr:line1><gtr:line4>Leiden</gtr:line4><gtr:line5>NL-2300 RC</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/55E3189A-E372-4C13-AD98-87C6C754D4B3"><gtr:id>55E3189A-E372-4C13-AD98-87C6C754D4B3</gtr:id><gtr:name>Babraham Bioscience Technologies</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CA10F5D0-8E26-4790-BF21-025009DDA322"><gtr:id>CA10F5D0-8E26-4790-BF21-025009DDA322</gtr:id><gtr:name>Medical University of Graz</gtr:name><gtr:address><gtr:line1>Harrachgasse 21</gtr:line1><gtr:line4>Graz</gtr:line4><gtr:line5>A-8010</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Austria</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7834FF12-A0B3-48E0-BA8C-39F517E844C4"><gtr:id>7834FF12-A0B3-48E0-BA8C-39F517E844C4</gtr:id><gtr:name>Government of Estonia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E594C221-4738-4152-9CFD-57F6EB31C620"><gtr:id>E594C221-4738-4152-9CFD-57F6EB31C620</gtr:id><gtr:name>Fraunhofer Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DA82066A-2B1B-412F-8D72-43273A319CA6"><gtr:id>DA82066A-2B1B-412F-8D72-43273A319CA6</gtr:id><gtr:name>Roche</gtr:name><gtr:address><gtr:line1>PRG Building 93 room 6 10</gtr:line1><gtr:line2>F Hoffman La Roche</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A620A19B-1A40-418A-B3FC-086E667D691D"><gtr:id>A620A19B-1A40-418A-B3FC-086E667D691D</gtr:id><gtr:name>Norwegian University of Science and Technology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/00866200-F62B-429B-BF02-A0A841684ED5"><gtr:id>00866200-F62B-429B-BF02-A0A841684ED5</gtr:id><gtr:name>University of Salamanca</gtr:name><gtr:address><gtr:line1>Universidad de Salamanca</gtr:line1><gtr:line2>Patio de Escuelas 1</gtr:line2><gtr:line4>Salamanca</gtr:line4><gtr:line5>37071</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D3CC600D-1AD4-4272-99C1-158BDF55308C"><gtr:id>D3CC600D-1AD4-4272-99C1-158BDF55308C</gtr:id><gtr:name>Alliance Against Cancer</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/326EF7F4-5944-472D-BC94-2CA4484AEE74"><gtr:id>326EF7F4-5944-472D-BC94-2CA4484AEE74</gtr:id><gtr:name>University of Groningen</gtr:name><gtr:address><gtr:line1>Postbus 72</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3F817F1C-4D4C-4325-A83C-601A871E5487"><gtr:id>3F817F1C-4D4C-4325-A83C-601A871E5487</gtr:id><gtr:name>ORION Pharma</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E3D2D81D-2671-410B-9D1C-BBBBDA8CF466"><gtr:id>E3D2D81D-2671-410B-9D1C-BBBBDA8CF466</gtr:id><gtr:name>Johnson &amp; Johnson Ltd</gtr:name><gtr:address><gtr:line1>Foundation Park</gtr:line1><gtr:line2>Roxborough Way</gtr:line2><gtr:line4>Maidenhead</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>SLG 3UG</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A41945D6-8D29-453B-9D65-95BA3A272A1D"><gtr:id>A41945D6-8D29-453B-9D65-95BA3A272A1D</gtr:id><gtr:name>International Rare Diseases Research Consortium (IRDiRC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DD698BE9-1ED7-42BF-AC5D-427A5CA5851D"><gtr:id>DD698BE9-1ED7-42BF-AC5D-427A5CA5851D</gtr:id><gtr:name>Bayer</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/ADD77807-7B00-4A41-A7A4-09A5D0BB801C"><gtr:id>ADD77807-7B00-4A41-A7A4-09A5D0BB801C</gtr:id><gtr:name>Esteve</gtr:name><gtr:address><gtr:line1>Avda. Mare de Deu de Montserrat, 221</gtr:line1><gtr:postCode>E-08041</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/82321AD2-CD2E-456C-9395-59CF155A3EC8"><gtr:id>82321AD2-CD2E-456C-9395-59CF155A3EC8</gtr:id><gtr:name>Sanofi</gtr:name><gtr:address><gtr:line1>174 avenue de France</gtr:line1><gtr:line4>Paris cedex 13</gtr:line4><gtr:postCode>75635</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/712757B9-CD96-4383-A0F9-F0D7F1B4951C"><gtr:id>712757B9-CD96-4383-A0F9-F0D7F1B4951C</gtr:id><gtr:name>Vitro (Biobanking services)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/98C379BE-5412-4C64-9838-F46315C76505"><gtr:id>98C379BE-5412-4C64-9838-F46315C76505</gtr:id><gtr:name>Health Research Board (HRB)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8F8BCFC1-FF94-4796-B5E0-5A64B0C3AB6C"><gtr:id>8F8BCFC1-FF94-4796-B5E0-5A64B0C3AB6C</gtr:id><gtr:name>Autonomous University of Madrid</gtr:name><gtr:address><gtr:line1>Ciudad Universitaria de Cantoblanco</gtr:line1><gtr:line2>C/Francisco Tomas y Valiente, 1</gtr:line2><gtr:line4>Madrid</gtr:line4><gtr:line5>E-28049</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/314A3F92-9F78-4782-891F-990F9E739DC4"><gtr:id>314A3F92-9F78-4782-891F-990F9E739DC4</gtr:id><gtr:name>Medical University of Vienna</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/6A5D0F02-E386-44C0-BBAE-17AAC62AF2BA"><gtr:id>6A5D0F02-E386-44C0-BBAE-17AAC62AF2BA</gtr:id><gtr:name>Netherlands Federation of University Medical Centres (NFU)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/6C747631-6855-48CC-BF64-0316AABB5DF8"><gtr:id>6C747631-6855-48CC-BF64-0316AABB5DF8</gtr:id><gtr:name>University of Malta</gtr:name><gtr:address><gtr:line1>Administration Bldg</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/61D20CC7-787C-455B-936A-3E16D0122205"><gtr:id>61D20CC7-787C-455B-936A-3E16D0122205</gtr:id><gtr:name>Semmelweis University</gtr:name><gtr:address><gtr:line1>Semmelweis University</gtr:line1><gtr:line2>Alkotas u. 44</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/620DB27D-4014-4278-AAD1-11105CC6BDEA"><gtr:id>620DB27D-4014-4278-AAD1-11105CC6BDEA</gtr:id><gtr:name>Novo Nordisk</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5A8C32C1-29FC-4B3A-8C07-C792DC7AF31B"><gtr:id>5A8C32C1-29FC-4B3A-8C07-C792DC7AF31B</gtr:id><gtr:name>Legal Pathways Institute for Health and Bio-Law</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5F32098B-3CD7-41E1-BD83-220F3383C071"><gtr:id>5F32098B-3CD7-41E1-BD83-220F3383C071</gtr:id><gtr:name>Spanish Ministry of Science and Innovation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A2EE26A2-8275-447D-9B11-61E0674537F5"><gtr:id>A2EE26A2-8275-447D-9B11-61E0674537F5</gtr:id><gtr:firstName>William</gtr:firstName><gtr:otherNames>Osmond</gtr:otherNames><gtr:surname>Cookson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/31306DBD-0EEB-4684-9CA0-B35B5C0B52F1"><gtr:id>31306DBD-0EEB-4684-9CA0-B35B5C0B52F1</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Owen</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9C559096-8F19-465C-87D0-1DBFFA282F5F"><gtr:id>9C559096-8F19-465C-87D0-1DBFFA282F5F</gtr:id><gtr:firstName>Judith</gtr:firstName><gtr:otherNames>Anne</gtr:otherNames><gtr:surname>Goodship</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9FAD231C-DA2D-4CBD-A1F3-BF11E5203F4E"><gtr:id>9FAD231C-DA2D-4CBD-A1F3-BF11E5203F4E</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>McGuffin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8ABECAD9-8B53-4898-91DD-B5C5A1A0459B"><gtr:id>8ABECAD9-8B53-4898-91DD-B5C5A1A0459B</gtr:id><gtr:firstName>Carl</gtr:firstName><gtr:surname>Clarke</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0486B5FC-45CA-442A-A0F9-215D29A01AB4"><gtr:id>0486B5FC-45CA-442A-A0F9-215D29A01AB4</gtr:id><gtr:firstName>Karen Elaine</gtr:firstName><gtr:surname>Morrison</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/BE2F9B1E-AFE2-4470-8947-A37BAA446C40"><gtr:id>BE2F9B1E-AFE2-4470-8947-A37BAA446C40</gtr:id><gtr:firstName>Miriam</gtr:firstName><gtr:otherNames>Fleur</gtr:otherNames><gtr:surname>Moffatt</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A81109F6-7B27-4E09-A5ED-DE8FCEA82F38"><gtr:id>A81109F6-7B27-4E09-A5ED-DE8FCEA82F38</gtr:id><gtr:firstName>Malcolm</gtr:firstName><gtr:otherNames>Graham</gtr:otherNames><gtr:surname>Dunlop</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C9B069BD-5D15-43B4-B0D6-6A64211DC850"><gtr:id>C9B069BD-5D15-43B4-B0D6-6A64211DC850</gtr:id><gtr:firstName>Ellen</gtr:firstName><gtr:surname>Solomon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4BD46A99-6CCE-45C4-A615-3C8DBE0AC41D"><gtr:id>4BD46A99-6CCE-45C4-A615-3C8DBE0AC41D</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Rees</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D5931BD0-9118-40A8-83E7-F0BDAB9FF707"><gtr:id>D5931BD0-9118-40A8-83E7-F0BDAB9FF707</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:otherNames>Alexander</gtr:otherNames><gtr:surname>Yuille</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/43021168-77AE-40B4-862F-AB4797FCA87F"><gtr:id>43021168-77AE-40B4-862F-AB4797FCA87F</gtr:id><gtr:firstName>Harry</gtr:firstName><gtr:surname>Campbell</gtr:surname><gtr:orcidId>0000-0002-6169-6262</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A64B614B-387F-4A87-8F08-18C3C2916676"><gtr:id>A64B614B-387F-4A87-8F08-18C3C2916676</gtr:id><gtr:firstName>Julie</gtr:firstName><gtr:surname>Williams</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5424B5E5-25D2-4542-94FD-959A58B8EE69"><gtr:id>5424B5E5-25D2-4542-94FD-959A58B8EE69</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>Royston</gtr:otherNames><gtr:surname>Webster</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/63454C57-257F-4FAE-8D1D-410381F0B810"><gtr:id>63454C57-257F-4FAE-8D1D-410381F0B810</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Hattersley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/BB440D9D-19FD-47E8-9F9D-5D0F7899E02B"><gtr:id>BB440D9D-19FD-47E8-9F9D-5D0F7899E02B</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Lewis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0BAAB362-6169-494D-B44C-9A9A56971C78"><gtr:id>0BAAB362-6169-494D-B44C-9A9A56971C78</gtr:id><gtr:firstName>Shomi</gtr:firstName><gtr:surname>Bhattacharya</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/383EE2D6-5E49-4064-AE3A-95B17D7CA76D"><gtr:id>383EE2D6-5E49-4064-AE3A-95B17D7CA76D</gtr:id><gtr:firstName>Patricia</gtr:firstName><gtr:surname>Munroe</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/38125C45-5239-4F7C-A939-4140F109A5F2"><gtr:id>38125C45-5239-4F7C-A939-4140F109A5F2</gtr:id><gtr:firstName>Alistair</gtr:firstName><gtr:otherNames>Scott</gtr:otherNames><gtr:surname>Hall</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2165B74E-9235-4B68-B481-EAB07E3083A9"><gtr:id>2165B74E-9235-4B68-B481-EAB07E3083A9</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Caulfield</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EB134AF9-197A-4970-8C8E-6D9132EBEB02"><gtr:id>EB134AF9-197A-4970-8C8E-6D9132EBEB02</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:otherNames>Ian</gtr:otherNames><gtr:surname>McCarthy</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/801F3019-88AB-4A46-98EB-E90FBC781DBE"><gtr:id>801F3019-88AB-4A46-98EB-E90FBC781DBE</gtr:id><gtr:firstName>Nilesh</gtr:firstName><gtr:otherNames>Jayantilal</gtr:otherNames><gtr:surname>Samani</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/147A4A54-6D76-463F-99BD-C21F5AB451A4"><gtr:id>147A4A54-6D76-463F-99BD-C21F5AB451A4</gtr:id><gtr:firstName>Alastair</gtr:firstName><gtr:surname>Compston</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4298678A-F46A-4F04-8148-6ED71C2A9150"><gtr:id>4298678A-F46A-4F04-8148-6ED71C2A9150</gtr:id><gtr:firstName>William</gtr:firstName><gtr:surname>Ollier</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0600237"><gtr:id>F6907B23-7016-49D8-8F58-38ADC0E2FC6C</gtr:id><gtr:title>The UK DNA Banking Network</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600237</gtr:grantReference><gtr:abstractText>The UK DNA Banking Network (UDBN at www.dna-network.ac.uk) manages data and sample collections for common human diseases. High quality management is essential for genetic epidemiology. It saves time and money; allows UK scientists access to these valuable resources; and allows the gathering together of the large series that are now essential to find genes underlying common diseases. Already six of the collections have been used in this way with &amp;gt;6 billion genetic variants tested in &amp;gt;12,000 samples. Round the world, genetic epidemiologists are trying to tackle the huge logistic problems associated with these numbers. UDBN has solved most of them. No other nation has yet got this sort of infrastructure. We now plan to speed up the process of making collections for more diseases so that more genes will be found quicker and cheaper. We want to see UDBN serve the needs of all collectors - not only those funded by MRC. We also want to ensure that the management we provide remains at the cutting edge of robotics and informatics. Our current collections are in Coronary Artery Disease; Colorectal cancer; Glomerulonephritis; Parkinson?s Disease; Asthma; Eczema; Type 2 Diabetes; Breast Cancer; Hypertension; Multiple Sclerosis; Alzheimer?s Disease; Macular Degeneration; Unipolar Depression.</gtr:abstractText><gtr:technicalSummary>A national community resource has been created for DNA sample and data management to support UK scientists investigating genetic risk factors in 13 high impact diseases. The resource - the UK DNA Banking Network - comprises ISO 2001 facilities in CIGMR (Manchester) and ECACC (Salisbury) for managing DNA and cell samples respectively. The facilities make extensive use of robotics supported by LIMS. The Network has a highly functional website that provides a ?Collaboration Service? akin to a dating agency for collaboration. This service involves linking of CIGMR and ECACC LIMS with collectors? phenotype databases. UDBN collections are being analysed in high density genome wide association and other studies. This community resource is the most advanced of its kind.

UDBN seeks renewed support to retain this world-leading position. Support will allow us to promote wider use of the samples; to sustain the Network; to maintain its infrastructure; to complete the data management infrastructure; to roll out the management capabilities for other human disease collections (including clinical trials); massively to save costs to all funding bodies planning to support new collections; to adapt UDBN?s organisation as links to other funders grow; to test revenue streams for UDBN that will ensure cost-effective use of resources and to implement a programme of research and development. This programme will achieve wider harmonisation of DNA sample management processes; will conserve irreplaceable genomic DNA samples; will facilitate DNA sample accrual from rarer diseases or sub-types (from wax blocks); and will facilitate accrual of further sub-cellular fractions (RNA) for high throughput analysis.</gtr:technicalSummary><gtr:fund><gtr:end>2010-01-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>825352</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>50362253-2767-4E74-A589-1AB74EF62187</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>6DABDADB-62D5-449F-81FD-E2A4B3CF4AE5</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Groningen</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>University Medical Center Gronigen</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>C6DB5A21-6F22-42AA-BD20-11C5C1605450</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Max Planck Institute for Molecular Genetics</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>EFA0BAAB-F282-4C73-A489-2E6F4E293A60</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Federal Ministry of Science, Research and Economy (BMWFW)</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>557468A8-E7AB-4D94-BF3A-ACDD85A7D639</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Norwegian University of Science and Technology</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>136A0B14-E2C1-4B93-A490-145C64BE69D2</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Almirall</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>002AA541-B8FB-4EE1-939D-F3D1BBF54CD8</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sanofi-Aventis</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Genzyme Corporation</gtr:department><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>2EEEFC6C-64E1-4830-B0E4-82F0BE841DEA</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helmholtz Association of German Research Centres</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>60A58B79-D9E6-49B3-890E-E594D11E3716</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Italian National Health Service</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Istituto Superiore di Sanit? (ISS)</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>07973681-C365-4565-B718-778D0EB272DE</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Stratum</gtr:description><gtr:id>C9DEFE58-49E5-44A8-90FF-CBA774D636C8</gtr:id><gtr:impact>Too soon</gtr:impact><gtr:piContribution>Financial modelling for national biobanking solutions</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Netherlands Federation of University Medical Centres (NFU)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>2A130D25-BD27-4023-A636-F5D13AD62DEE</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>German Federal Ministry of Education and Research</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>E93B7E9A-F64E-4A5D-BA93-ACF739BBB5D2</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical University of Graz</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>A67F1A37-5451-49F7-9B38-F6A2F96125D0</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lundbeck Foundation</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>3B7E2BDF-C348-4185-8002-2CA10B3620B8</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Klagenfurt (Alpen-Adria-Universit?t Klagenfurt)</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>67822E57-FD8B-49BC-AD51-A1978279D02B</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Vitro (Biobanking services)</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>5913B443-EE02-4D1A-884C-64E22806DAC2</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Erasmus University Rotterdam (Erasmus Universitair Medisch Centrum EUR)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>University Medical Center</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>4499221B-584B-4004-A2D3-244C21376907</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Alliance Against Cancer</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>D368A24A-5EB1-430C-A5F3-1C871E4471DC</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>C.H. Boehringer Sohn AG &amp; Ko. KG</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Boehringer Ingelheim</gtr:department><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>1B78D621-00F0-47BF-9362-F442FCC3896F</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>ORION Pharma</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>85BE5973-3599-4782-8E48-D9261E0B2A7F</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Netherlands Organisation for Health Research and Development (ZonMw)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>C79DB0EB-E3EF-4AC3-8CD1-61C2C8385D00</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oslo</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:department>Norwegian Institute of Public Health</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>DDA2167E-CDF6-480B-A480-6B1DEE143532</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sanofi</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Sanofi-Aventis</gtr:department><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>81C54396-969B-4E07-8F9C-239D7CFAA72C</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Research Council of Italy CNR</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>ITB CNR Institute for Biomedical Technologies</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>9B6A6A5B-A7D3-4C09-B7D8-9522306EBDD0</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Economics and Political Science (University of London)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>BB991913-8B5A-4938-A523-766D0D064376</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Vienna</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:department>Life Science Governance Institute, Vienna</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>58200B15-91BD-41BB-82B6-ECAD3B83AC68</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Spanish Ministry of Science and Innovation</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Institute of Health &quot;Carlos III&quot; (ISCIII)</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>6CB1B0BA-206D-4A77-A7B4-81758D20C566</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>deCODE genetics</gtr:collaboratingOrganisation><gtr:country>Iceland, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>93B38E4F-C013-4057-90CD-A5AA6F4B745D</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>UK Biobank</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>693563E7-0619-45B6-8E0E-983A59C9E755</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Cancer Research, Genoa (IST) (Istituto Nazionale per la Ricerca sul Cancro di Genova)</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>BA3E399A-777C-4D19-90EF-FA00AAF96AA6</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Uppsala</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>581DDE16-3AE4-4483-B056-EA542EB6C5D0</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Semmelweiss University</gtr:collaboratingOrganisation><gtr:country>Hungary, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>1901F7D4-0507-4E2F-9191-441943B1602A</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Salamanca</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>218CEBB4-D78C-49AB-8F18-9D2DC97BF706</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Tartu</gtr:collaboratingOrganisation><gtr:country>Estonia, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>B75111BD-8680-4A30-84CC-543B707858EE</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Health Research Board (HRB)</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>5E9BF977-071D-4446-88D2-1BA47015D60F</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Rare Diseases Research Consortium (IRDiRC)</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Telethon Foundation</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>4327595F-39B1-464F-B0E6-8E82021BEA8F</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Government of Estonia</gtr:collaboratingOrganisation><gtr:country>Estonia, Republic of</gtr:country><gtr:department>Ministry of Education and Research Estonia</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>710E0659-1F0D-4938-A4F5-6E8E8522BF88</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Agency for Research on Cancer (IARC)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>A9043999-DCB9-4132-8C9B-BBAF88A542FA</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Esteve</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>7CC6BC2E-F129-498B-8049-1C18D0803509</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska University Hospital</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>DC2BC42E-C531-4823-8919-46DD855292F8</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Division of Metabolic Diseases</gtr:department><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>09ABDC2C-107C-4361-8FB6-6B9D327B5C0C</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Fraunhofer Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>The Fraunhofer Institute for Biomedical Engineering (IBMT)</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>7DB73A2D-D32C-4FE2-A278-6DF8590F4229</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Government of France</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>F?d?ration Hospitali?re de France (FHF)</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>8C6FBE95-9DC6-408F-88AF-A55158BBE27B</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>FCCB0EFB-D9CA-4026-97AF-B548DD72779A</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>1A6AE1D6-1F00-406E-9B01-4C33A08B3C12</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>0FCA2EFA-9DB1-458C-B0C9-03BD24B4067D</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Malta</gtr:collaboratingOrganisation><gtr:country>Malta, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>721C3733-D73B-415D-9379-81BFCB18C7B7</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College Hospital NHS Foundation Trust (NCH)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Acropolis</gtr:description><gtr:id>3DBFD39B-9C9E-484E-800F-AE52A5AF1CF9</gtr:id><gtr:impact>Too soon</gtr:impact><gtr:piContribution>Management of data integration project for research between MAHSC and KHP</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>23E7C7D3-D077-4B87-8C67-EABE2DA28F9C</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bayer</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>799245AF-5C9B-49A9-996A-501CEDBE7CBB</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hellenic Republic Ministry of Development</gtr:collaboratingOrganisation><gtr:country>Greece, Hellenic Republic</gtr:country><gtr:department>General Secretariat For Research &amp; Technology</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>4CC302D1-8D4C-4C8B-8B71-72CF90BA2C8F</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helmholtz Association of German Research Centres</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>German Research Centre for Environmental Health</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>D7B2B6F8-98E5-4366-9A8D-10EE6E68D7DC</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leiden University Medical Center (LUMC)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>A360BCF3-FBF7-4E50-9141-9AD4BEE941E1</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Molecular Medicine Ireland</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:department>Irish Clinical Research Infrastructure Network (ICRIN)</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>B69A1E0E-8074-4F5F-A3FC-79DACE9633F5</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Legal Pathways Institute for Health and Bio-Law</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>2ACD9CBF-ACB0-4CDC-9FAF-CD3CEE1B8F03</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Babraham Bioscience Technologies</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>E3DE6CAC-07A3-4DB0-A26F-50E0C0A46343</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical University of Graz</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>B5ED67D3-3A47-4E5A-9D23-D9F9405FFB74</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Roche</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Hoffmann-La Roche</gtr:department><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>F9A774E6-65C5-4DDB-BE50-BD398B0E4A21</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>0EE20F12-CD19-48E1-A85F-A69B3F8C5EAE</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Autonomous University of Madrid (Universidad Aut?noma de Madrid UAM)</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>2F8E1B7D-F24C-4AE9-916E-9D277B0CBB67</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Government of the Netherlands</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Ministry of Education, Culture and Science Netherlands</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>30F00A76-9C1E-40EC-89CB-BE68DF801275</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helmholtz Association of German Research Centres</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Helmholtz Centre for Infection Research (HZI)</gtr:department><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>0AAA64BC-BF79-410D-8CCB-779A54360AD5</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>67653EAE-4BE3-4924-BFAF-B10477583C0A</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helmholtz Association of German Research Centres</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>German Research Centre for Environmental Health</gtr:department><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>3C3C2EB0-BF20-433E-AAF7-BE6B3D76A0EF</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Molecular Biology Laboratory (EMBL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>European Bioinformatics Institute (EBI)</gtr:department><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>7604A344-9B7F-461B-9410-9BEAAD06E622</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical University of Vienna</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>67C4CA7D-9116-4264-AC19-CB329B00913B</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>UCB Pharma</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>C5CDCD68-F59D-495C-ADA6-282BD475C256</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Molecular Biology Laboratory (EMBL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>European Bioinformatics Institute (EBI)</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>3126062E-BBF6-4C96-8E37-599139B43E0C</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Icelandic Centre for Research (RANN?S)</gtr:collaboratingOrganisation><gtr:country>Iceland, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>504FBD53-18C1-4C0F-9344-C626E294D4CD</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johnson &amp; Johnson</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>46EF45D7-0A59-457C-B87C-C2707F9B1D9A</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novo Nordisk</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>2FE1AD3D-689B-40CC-9896-FCAB04CA529F</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>4D68ECA0-E96A-42B8-A76F-269B2AF1F9AF</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Academic Medical Center (AMC)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Department of Respiratory Medicine</gtr:department><gtr:description>IMI U-biopred</gtr:description><gtr:id>2D9E9A53-9345-40AB-B6E2-F3CE8816F3E2</gtr:id><gtr:impact>Too soon</gtr:impact><gtr:piContribution>Biobanking infrastructure</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Academy of Athens</gtr:collaboratingOrganisation><gtr:country>Greece, Hellenic Republic</gtr:country><gtr:department>Biomedical Research Foundation Academy of Athens</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>BC20287E-8F06-4277-8672-1047C65921E6</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>UDBN website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>56F4605D-485A-4523-A066-94DFE1234076</gtr:id><gtr:impact>Website with open access and access restricted to registered users deemed to be bona fide researchers by UDBN. Restricted access permits search of phenotype data with results in summary form only.

UDBN has distributed 80,000 DNA samples for numerous studies in part through use of the website.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Manchester Academic Health Science Centre</gtr:department><gtr:description>Manchester Academic Health Science Centre Pilot Funding/University of Manchester</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>University of Manchester</gtr:fundingOrg><gtr:id>0D246364-1C00-4D85-9D31-8894AD57EE9A</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7-INFRASTRUCTURES-2007-1</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Community Research and Development Information Service (CORDIS)</gtr:fundingOrg><gtr:id>7A0A3D8C-4BC8-4727-A2D9-646AAD9A5D4F</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2007-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Innovative Medicines Initiative (IMI) Call 1 Topic 14</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:id>E50CA53E-22D2-453F-BC1E-BAF7D321AD33</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Confederation of Cancer Biobanking</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>4FD51D5B-C68F-4946-B4D3-54767E5D11CB</gtr:id><gtr:impact>no</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>GeneLibrary Ireland</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>A9C332F9-AA24-4A3E-A61F-127766D4B6B6</gtr:id><gtr:impact>None</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This Collaboration Management System permits the initiation of collaborations between resource owners in UDBN and third parties.</gtr:description><gtr:id>F1EFA2E4-E7AC-4984-9961-2D6F136EDE00</gtr:id><gtr:impact>UDBN has distributed 80,000 aliquots to researchers involved in different collaborative arrangements.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CoMS</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Permits centralised web-based project management of collection activities (track sample; track consent; phenotype data entry).</gtr:description><gtr:id>D1FE03A3-443B-48D2-9063-906E834518B0</gtr:id><gtr:impact>Too early to say</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>PRELIMS</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A1BE4199-53CD-442C-A6AA-3EE60B86F0A0"><gtr:id>A1BE4199-53CD-442C-A6AA-3EE60B86F0A0</gtr:id><gtr:title>The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f460767649781454eba53de21a508d00"><gtr:id>f460767649781454eba53de21a508d00</gtr:id><gtr:otherNames>Ehret GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BDD54B46-6F39-4C30-88D5-29F19F61E869"><gtr:id>BDD54B46-6F39-4C30-88D5-29F19F61E869</gtr:id><gtr:title>ADAMTS7 cleavage and vascular smooth muscle cell migration is affected by a coronary-artery-disease-associated variant.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fe74d2d69d2455ab01cab4633ffc29ce"><gtr:id>fe74d2d69d2455ab01cab4633ffc29ce</gtr:id><gtr:otherNames>Pu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4239B0C2-F2F7-4654-A34B-36E60A0CCCE9"><gtr:id>4239B0C2-F2F7-4654-A34B-36E60A0CCCE9</gtr:id><gtr:title>Observational study on variability between biobanks in the estimation of DNA concentration.</gtr:title><gtr:parentPublicationTitle>BMC research notes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d99186fe36784093a89ae67dc4a70fcb"><gtr:id>d99186fe36784093a89ae67dc4a70fcb</gtr:id><gtr:otherNames>Brown J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1756-0500</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/19DF1ED3-2533-4711-BD23-0A8D2F40F22C"><gtr:id>19DF1ED3-2533-4711-BD23-0A8D2F40F22C</gtr:id><gtr:title>Enhanced vasodilator activity of nitrite in hypertension: critical role for erythrocytic xanthine oxidoreductase and translational potential.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/643b1b617e1aee683833a188215b7d78"><gtr:id>643b1b617e1aee683833a188215b7d78</gtr:id><gtr:otherNames>Ghosh SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BF027304-C153-4310-86AF-22720DF4148E"><gtr:id>BF027304-C153-4310-86AF-22720DF4148E</gtr:id><gtr:title>Advances in blood pressure genomics.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/490fed85c84528133103e9ef4adcdc76"><gtr:id>490fed85c84528133103e9ef4adcdc76</gtr:id><gtr:otherNames>Munroe PB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9E45ED9B-7E67-4BD5-9409-E9BF5C6594EC"><gtr:id>9E45ED9B-7E67-4BD5-9409-E9BF5C6594EC</gtr:id><gtr:title>Comprehensive catalog of European biobanks.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a340e639801a1ed725f7c06ac5657ad7"><gtr:id>a340e639801a1ed725f7c06ac5657ad7</gtr:id><gtr:otherNames>Wichmann HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C9023CFA-0C0E-4D4E-B758-FAE9B7E3685F"><gtr:id>C9023CFA-0C0E-4D4E-B758-FAE9B7E3685F</gtr:id><gtr:title>Genes for blood pressure: an opportunity to understand hypertension.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f460767649781454eba53de21a508d00"><gtr:id>f460767649781454eba53de21a508d00</gtr:id><gtr:otherNames>Ehret GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8C28AA8C-090A-4F60-8966-5283B9002FC9"><gtr:id>8C28AA8C-090A-4F60-8966-5283B9002FC9</gtr:id><gtr:title>Infrastructure vital to genome success.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdc4dcc726a87babd2e7d3f602462e8c"><gtr:id>bdc4dcc726a87babd2e7d3f602462e8c</gtr:id><gtr:otherNames>Yuille M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/129D34AB-7698-499D-BB08-2301C41FDDD2"><gtr:id>129D34AB-7698-499D-BB08-2301C41FDDD2</gtr:id><gtr:title>Increased NBCn1 expression, Na+/HCO3- co-transport and intracellular pH in human vascular smooth muscle cells with a risk allele for hypertension.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/80c16835b332272f8c178d01a34d8a3b"><gtr:id>80c16835b332272f8c178d01a34d8a3b</gtr:id><gtr:otherNames>Ng FL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/997B24DB-5577-4EF3-85F8-3DCBC6D4AFC4"><gtr:id>997B24DB-5577-4EF3-85F8-3DCBC6D4AFC4</gtr:id><gtr:title>Genome-wide analysis of blood pressure variability and ischemic stroke.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dd8ab34f59180cdb6c4e8422460c89d6"><gtr:id>dd8ab34f59180cdb6c4e8422460c89d6</gtr:id><gtr:otherNames>Yadav S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9F89E036-3BB9-4431-9992-21AE92F36CD6"><gtr:id>9F89E036-3BB9-4431-9992-21AE92F36CD6</gtr:id><gtr:title>The UK DNA banking network: a &amp;quot;fair access&amp;quot; biobank.</gtr:title><gtr:parentPublicationTitle>Cell and tissue banking</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdc4dcc726a87babd2e7d3f602462e8c"><gtr:id>bdc4dcc726a87babd2e7d3f602462e8c</gtr:id><gtr:otherNames>Yuille M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1389-9333</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/862AA630-EC24-48BF-BF65-496D49590F3D"><gtr:id>862AA630-EC24-48BF-BF65-496D49590F3D</gtr:id><gtr:title>Loci influencing blood pressure identified using a cardiovascular gene-centric array.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a2c3233fe4bf0a3e0f9dddb16e1aa7fa"><gtr:id>a2c3233fe4bf0a3e0f9dddb16e1aa7fa</gtr:id><gtr:otherNames>Ganesh SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/74607975-F026-40AC-AEC0-BAE0361E808E"><gtr:id>74607975-F026-40AC-AEC0-BAE0361E808E</gtr:id><gtr:title>Molecular medicine ireland guidelines for standardized biobanking.</gtr:title><gtr:parentPublicationTitle>Biopreservation and biobanking</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ce1b7cf85390d9551608a9b1de3e6dc"><gtr:id>8ce1b7cf85390d9551608a9b1de3e6dc</gtr:id><gtr:otherNames>Guerin JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1947-5543</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/25DFEF9E-350D-4533-87BC-F78D2C55EDDB"><gtr:id>25DFEF9E-350D-4533-87BC-F78D2C55EDDB</gtr:id><gtr:title>Laboratory management of samples in biobanks: European consensus expert group report.</gtr:title><gtr:parentPublicationTitle>Biopreservation and biobanking</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdc4dcc726a87babd2e7d3f602462e8c"><gtr:id>bdc4dcc726a87babd2e7d3f602462e8c</gtr:id><gtr:otherNames>Yuille M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1947-5543</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D0051BF3-9C9A-4878-AD57-58157DB52C35"><gtr:id>D0051BF3-9C9A-4878-AD57-58157DB52C35</gtr:id><gtr:title>Mutations in the TGF-? repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f4297d28bf106a488fb65510b6434eb2"><gtr:id>f4297d28bf106a488fb65510b6434eb2</gtr:id><gtr:otherNames>Doyle AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2DCF42E3-5F54-42A0-9ABE-08983D3DB715"><gtr:id>2DCF42E3-5F54-42A0-9ABE-08983D3DB715</gtr:id><gtr:title>Familial chronic lymphocytic leukemia in Norway and Denmark. Comments on pleiotropy and birth order.</gtr:title><gtr:parentPublicationTitle>In vivo (Athens, Greece)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce77a2d7bab1bb5f89f650ba9b78317c"><gtr:id>ce77a2d7bab1bb5f89f650ba9b78317c</gtr:id><gtr:otherNames>J?nsson V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0258-851X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A2AD558F-1E59-4C2A-A60F-EC727AA076B5"><gtr:id>A2AD558F-1E59-4C2A-A60F-EC727AA076B5</gtr:id><gtr:title>Common polymorphisms in the CYP11B1 and CYP11B2 genes: evidence for a digenic influence on hypertension.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bc470cd2f13415638d337587c37a73f5"><gtr:id>bc470cd2f13415638d337587c37a73f5</gtr:id><gtr:otherNames>Alvarez-Madrazo S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0E5A89B2-2E56-4FC3-A260-089B49DB6BA2"><gtr:id>0E5A89B2-2E56-4FC3-A260-089B49DB6BA2</gtr:id><gtr:title>A blood pressure-associated variant of the SLC39A8 gene influences cellular cadmium accumulation and toxicity.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/55ccc78aeedcc3165e7329451a088c1c"><gtr:id>55ccc78aeedcc3165e7329451a088c1c</gtr:id><gtr:otherNames>Zhang R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9F1E29C8-0F43-4A8B-A2CB-25ACAB73DBF6"><gtr:id>9F1E29C8-0F43-4A8B-A2CB-25ACAB73DBF6</gtr:id><gtr:title>Rare and low-frequency coding variants alter human adult height.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e375f8da269c5aef74fdc314da8bf29d"><gtr:id>e375f8da269c5aef74fdc314da8bf29d</gtr:id><gtr:otherNames>Marouli E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F5D6286D-A4C7-422A-96C2-B18A09019750"><gtr:id>F5D6286D-A4C7-422A-96C2-B18A09019750</gtr:id><gtr:title>Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/10a99866f7b13a77e5429d4ee9ca8c09"><gtr:id>10a99866f7b13a77e5429d4ee9ca8c09</gtr:id><gtr:otherNames>Warren HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CB4D4DB6-E87C-4EFD-A02A-C7DD39668533"><gtr:id>CB4D4DB6-E87C-4EFD-A02A-C7DD39668533</gtr:id><gtr:title>Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4fc4eefd621187bd6531525a0d279e47"><gtr:id>4fc4eefd621187bd6531525a0d279e47</gtr:id><gtr:otherNames>Surendran P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F3FBFAEB-D78B-47FA-9884-EFBA15EE9B77"><gtr:id>F3FBFAEB-D78B-47FA-9884-EFBA15EE9B77</gtr:id><gtr:title>A genetic risk score is associated with statin-induced low-density lipoprotein cholesterol lowering.</gtr:title><gtr:parentPublicationTitle>Pharmacogenomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a5d1f0ca8ca1ec9664a9c61bebc2d80f"><gtr:id>a5d1f0ca8ca1ec9664a9c61bebc2d80f</gtr:id><gtr:otherNames>Leusink M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1462-2416</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FE9E3DE2-F956-470C-82AD-720322B8EA04"><gtr:id>FE9E3DE2-F956-470C-82AD-720322B8EA04</gtr:id><gtr:title>Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/37de4479f1759b4f36885d27564d5018"><gtr:id>37de4479f1759b4f36885d27564d5018</gtr:id><gtr:otherNames>K?ttgen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D9F3600E-ED31-4AA6-BFAF-57EDC47FF512"><gtr:id>D9F3600E-ED31-4AA6-BFAF-57EDC47FF512</gtr:id><gtr:title>Biobanking for Europe.</gtr:title><gtr:parentPublicationTitle>Briefings in bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdc4dcc726a87babd2e7d3f602462e8c"><gtr:id>bdc4dcc726a87babd2e7d3f602462e8c</gtr:id><gtr:otherNames>Yuille M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1467-5463</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8049A1AC-5A87-4606-A052-1973E49ACCDA"><gtr:id>8049A1AC-5A87-4606-A052-1973E49ACCDA</gtr:id><gtr:title>Randomised, double-blind, placebo-controlled study investigating the effects of inorganic nitrate on vascular function, platelet reactivity and restenosis in stable angina: protocol of the NITRATE-OCT study.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/70018f9d9f7c4a600984bcc360c6decb"><gtr:id>70018f9d9f7c4a600984bcc360c6decb</gtr:id><gtr:otherNames>Rathod KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/88D792C4-E927-4FA1-9B84-EECDB4249B3D"><gtr:id>88D792C4-E927-4FA1-9B84-EECDB4249B3D</gtr:id><gtr:title>Meta-analysis of genome-wide association studies of HDL cholesterol response to statins.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0aabcf3318f5a7b593a0ea7608a3439b"><gtr:id>0aabcf3318f5a7b593a0ea7608a3439b</gtr:id><gtr:otherNames>Postmus I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/83127104-65A2-4AE7-ADA5-1FD33026DF74"><gtr:id>83127104-65A2-4AE7-ADA5-1FD33026DF74</gtr:id><gtr:title>Analysis with the exome array identifies multiple new independent variants in lipid loci.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/69dea32a060ad338472db49f9e53b2d8"><gtr:id>69dea32a060ad338472db49f9e53b2d8</gtr:id><gtr:otherNames>Kanoni S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/68EB4B53-5CB9-4EAA-B3C3-AC3C0DC7F799"><gtr:id>68EB4B53-5CB9-4EAA-B3C3-AC3C0DC7F799</gtr:id><gtr:title>Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bf701a8f3e746fa6cdbab8e1399f7fb8"><gtr:id>bf701a8f3e746fa6cdbab8e1399f7fb8</gtr:id><gtr:otherNames>Randall JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/426C30DA-E8D6-4C7C-BCFF-887BE99714B3"><gtr:id>426C30DA-E8D6-4C7C-BCFF-887BE99714B3</gtr:id><gtr:title>Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults.</gtr:title><gtr:parentPublicationTitle>Leukemia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a52ffd9a4a4bad60a58cb8d90aa9bcac"><gtr:id>a52ffd9a4a4bad60a58cb8d90aa9bcac</gtr:id><gtr:otherNames>de Tute R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0887-6924</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/19CEF951-B939-46AA-AE5F-9201B796836A"><gtr:id>19CEF951-B939-46AA-AE5F-9201B796836A</gtr:id><gtr:title>Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated?</gtr:title><gtr:parentPublicationTitle>Journal of cardiac failure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a8a4c1df097b481b80274a70709147e9"><gtr:id>a8a4c1df097b481b80274a70709147e9</gtr:id><gtr:otherNames>Mamas MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1071-9164</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3FAEC122-934E-4569-B40C-09D34A1ABD32"><gtr:id>3FAEC122-934E-4569-B40C-09D34A1ABD32</gtr:id><gtr:title>Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87d790de652f8364d93c11ebda0e9ec4"><gtr:id>87d790de652f8364d93c11ebda0e9ec4</gtr:id><gtr:otherNames>Pattaro C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/114AC277-E0B7-41D2-9D43-7AE8CA5BAC7C"><gtr:id>114AC277-E0B7-41D2-9D43-7AE8CA5BAC7C</gtr:id><gtr:title>2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/609f27a6069c218e75d993a26a7249b1"><gtr:id>609f27a6069c218e75d993a26a7249b1</gtr:id><gtr:otherNames>Mancia G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0F9FC81F-9D40-485A-8CFE-3D432E8B6476"><gtr:id>0F9FC81F-9D40-485A-8CFE-3D432E8B6476</gtr:id><gtr:title>Population genomics of cardiometabolic traits: design of the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) Consortium.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a06bcb25009e3fface332b51a9c2bf7b"><gtr:id>a06bcb25009e3fface332b51a9c2bf7b</gtr:id><gtr:otherNames>Shah T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FB85F418-5681-4053-9147-8F08CD740679"><gtr:id>FB85F418-5681-4053-9147-8F08CD740679</gtr:id><gtr:title>Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f2c39afe845e351135709b4da8652d2f"><gtr:id>f2c39afe845e351135709b4da8652d2f</gtr:id><gtr:otherNames>Berndt SI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600237</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>